Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 4 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML.
Blood Adv. 2022 Sep 13;6(17):5132-5145. doi: 10.1182/bloodadvances.2022007334.
Blood Adv. 2022.
PMID: 35728048
Free PMC article.
Clinical Trial.
Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy.
Miyamoto T, Sanford D, Tomuleasa C, Hsiao HH, Olivera LJE, Enjeti AK, Gimenez Conca A, Castillo TBD, Girshova L, Martelli MP, Guvenc B, Delgado A, Duan Y, Garbayo Guijarro B, Llamas C, Lee JH.
Miyamoto T, et al. Among authors: girshova l.
Leuk Lymphoma. 2022 Apr;63(4):928-938. doi: 10.1080/10428194.2021.2002321. Epub 2022 Feb 11.
Leuk Lymphoma. 2022.
PMID: 35147482
Item in Clipboard
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial.
Konopleva MY, Röllig C, Cavenagh J, Deeren D, Girshova L, Krauter J, Martinelli G, Montesinos P, Schäfer JA, Ottmann O, Petrini M, Pigneux A, Rambaldi A, Recher C, Rodriguez-Veiga R, Taussig D, Vey N, Yoon SS, Ott M, Muehlbauer S, Beckermann BM, Catalani O, Genevray M, Mundt K, Jamois C, Fenaux P, Wei AH.
Konopleva MY, et al. Among authors: girshova l.
Blood Adv. 2022 Jul 26;6(14):4147-4156. doi: 10.1182/bloodadvances.2021006303.
Blood Adv. 2022.
PMID: 35413116
Free PMC article.
Clinical Trial.
Item in Clipboard
Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation.
Bogdanov K, Kudryavtseva E, Fomicheva Y, Churkina I, Lomaia E, Girshova L, Osipov Y, Zaritskey A.
Bogdanov K, et al. Among authors: girshova l.
Pathophysiology. 2023 Aug 1;30(3):296-313. doi: 10.3390/pathophysiology30030024.
Pathophysiology. 2023.
PMID: 37606386
Free PMC article.
Item in Clipboard
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international study.
Ito T, Sanford D, Tomuleasa C, Hsiao HH, Olivera LJE, Enjeti AK, Conca AG, Del Castillo TB, Girshova L, Martelli MP, Guvenc B, Bui CN, Delgado A, Duan Y, Guijarro BG, Llamas C, Lee JH.
Ito T, et al. Among authors: girshova l.
Eur J Haematol. 2022 Jul;109(1):58-68. doi: 10.1111/ejh.13769. Epub 2022 Apr 13.
Eur J Haematol. 2022.
PMID: 35298049
Free PMC article.
Item in Clipboard
The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case report.
Shatilova A, Girshova L, Zaytsev D, Budaeva I, Mirolyubova Y, Ryzhkova D, Grozov R, Bogdanov K, Nikulina T, Motorin D, Zammoeva D, Efremova S, Ivanov V, Petukhov A, Alekseeva Y, Zaritskey A.
Shatilova A, et al. Among authors: girshova l.
BMC Womens Health. 2021 May 1;21(1):184. doi: 10.1186/s12905-021-01328-y.
BMC Womens Health. 2021.
PMID: 33933047
Free PMC article.
Item in Clipboard
Rapid Efficacy of Gemtuzumab Ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure.
Zaytsev D, Girshova L, Ivanov V, Budaeva I, Motorin D, Badaev R, Mirolubova J, Grobovenko E, Chitanava T, Zaykova E, Alexeeva J, Zaritskey A.
Zaytsev D, et al. Among authors: girshova l.
Biology (Basel). 2020 Feb 10;9(2):28. doi: 10.3390/biology9020028.
Biology (Basel). 2020.
PMID: 32050707
Free PMC article.
Item in Clipboard
Cite
Cite